These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36737523)

  • 41. Clinical application of
    Xu J; Li Y; Xu X; Zhang J; Zhang Y; Yu X; Huang D
    Ann Nucl Med; 2018 Aug; 32(7):446-452. PubMed ID: 29926342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Single-center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Partelli S; Muffatti F; Andreasi V; Giannone F; Rossi G; Palumbo D; Mapelli P; Schiavo Lena M; Arcidiacono PG; De Cobelli F; Picchio M; Doglioni C; Falconi M
    Ann Surg; 2022 Nov; 276(5):921-928. PubMed ID: 35930017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors.
    Merino-Casabiel X; Aller J; Arbizu J; García-Figueiras R; González C; Grande E; Jiménez-Fonseca P; Sevilla MI; Capdevila J
    Clin Transl Oncol; 2018 Dec; 20(12):1522-1528. PubMed ID: 29766455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.
    Hasegawa S; Kobayashi N; Tokuhisa M; Goto A; Takano S; Takada Y; Kaneta T; Mori R; Matsuyama R; Endo I; Yamanaka S; Nakajima A; Inoue T; Ichikawa Y
    Digestion; 2017; 96(1):13-20. PubMed ID: 28609761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice.
    Rust E; Hubele F; Marzano E; Goichot B; Pessaux P; Kurtz JE; Imperiale A
    Cancer Imaging; 2012 May; 12(1):173-84. PubMed ID: 22743056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advancements in pancreatic neuroendocrine tumors.
    Sadaria MR; Hruban RH; Edil BH
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5):477-90. PubMed ID: 23899286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative 3D Assessment of
    Adams LC; Bressem KK; Brangsch J; Reimann C; Nowak K; Brenner W; Makowski MR
    J Nucl Med; 2020 Jul; 61(7):1021-1027. PubMed ID: 31862798
    [No Abstract]   [Full Text] [Related]  

  • 51. The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (
    Lung MS; Hicks RJ; Pavlakis N; Link E; Jefford M; Thomson B; Wyld DK; Liauw W; Akhurst T; Kuru N; Michael M
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):150-157. PubMed ID: 32030887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications.
    Ban X; Mo S; Lu Z; Jia C; Shao H; Chang X; Mao X; Zhang Y; Pang J; Zhang Y; Yu S; Chen J
    Endocrine; 2022 Sep; 77(3):538-545. PubMed ID: 35708896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
    McCall CM; Shi C; Cornish TC; Klimstra DS; Tang LH; Basturk O; Mun LJ; Ellison TA; Wolfgang CL; Choti MA; Schulick RD; Edil BH; Hruban RH
    Am J Surg Pathol; 2013 Nov; 37(11):1671-7. PubMed ID: 24121170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
    Virgolini I; Gabriel M; Kroiss A; von Guggenberg E; Prommegger R; Warwitz B; Nilica B; Roig LG; Rodrigues M; Uprimny C
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2072-83. PubMed ID: 27174220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
    Farrell JM; Pang JC; Kim GE; Tabatabai ZL
    Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging of Pancreatic Neuroendocrine Neoplasms.
    Chiti G; Grazzini G; Cozzi D; Danti G; Matteuzzi B; Granata V; Pradella S; Recchia L; Brunese L; Miele V
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular imaging of gastroenteropancreatic neuroendocrine tumors.
    Miederer M; Weber MM; Fottner C
    Gastroenterol Clin North Am; 2010 Dec; 39(4):923-35. PubMed ID: 21093764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imaging of neuroendocrine tumors of the pancreas.
    Dromain C; Déandréis D; Scoazec JY; Goere D; Ducreux M; Baudin E; Tselikas L
    Diagn Interv Imaging; 2016 Dec; 97(12):1241-1257. PubMed ID: 27876341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroendocrine tumors of the pancreas: current concepts and controversies.
    Reid MD; Balci S; Saka B; Adsay NV
    Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.
    Lam AK; Ishida H
    Histol Histopathol; 2021 Apr; 36(4):367-382. PubMed ID: 33305819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.